Literature DB >> 7959198

Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis.

W R Connell1, I C Talbot, N Harpaz, N Britto, K H Wilkinson, M A Kamm, J E Lennard-Jones.   

Abstract

This study examined three features associated with colorectal carcinoma complicating ulcerative colitis: (a) the distribution of 157 cancers in 120 patients with ulcerative colitis treated at St Mark's Hospital between 1947 and 1992; (b) the frequency at which dysplasia was found at a distance from the tumour in 50 total proctocolectomy specimens in which an average of 27 histology blocks were reviewed, and (c) the five year survival rate according to Dukes's stage and participation in a surveillance programme. Of 157 carcinomas, 88 (56%) occurred in the rectosigmoid, 19 (12%) in the descending colon or splenic flexure, and 50 (32%) in the proximal colon. Among the 120 patients, the rectum or sigmoid colon contained cancer in 81 (67.5%). Dysplasia was detected in 41 of 50 reviewed proctocolectomy specimens (82%). Dysplasia distant to a malignancy occurred in 37 (74%); two were classified indefinite, probably positive, 19 were low grade, and 16 were high grade; in 18 specimens there was an elevated dysplastic lesion. Survival was related to the Dukes's stage: about 90% of patients with Dukes's A or B cancer were alive at five years. The five year survival of 16 patients in whom cancer developed during surveillance was 87% compared with 55% of 104 patients who did not participate in surveillance (p = 0.024).

Entities:  

Mesh:

Year:  1994        PMID: 7959198      PMCID: PMC1375017          DOI: 10.1136/gut.35.10.1419

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

2.  Precancer and carcinoma in chronic ulcerative colitis. A histopathological and clinical investigation.

Authors:  L Hultén; J Kewenter; C Ahrén
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

3.  Risk of malignant change in ulcerative colitis.

Authors:  J M Hinton
Journal:  Gut       Date:  1966-10       Impact factor: 23.059

4.  Carcinoma of the colon and rectum complicating chronic ulcerative colitis.

Authors:  J A van Heerden; R W Beart
Journal:  Dis Colon Rectum       Date:  1980-04       Impact factor: 4.585

5.  The risk of cancer following colectomy and ileorectal anastomosis for extensive mucosal ulcerative colitis.

Authors:  S F Grundfest; V Fazio; R A Weiss; D Jagelman; I Lavery; F L Weakley; R B Turnbull
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

6.  Survival with carcinoma arising in mucosal ulcerative colitis.

Authors:  I C Lavery; R A Chiulli; D G Jagelman; V W Fazio; F L Weakley
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

7.  Cancer of the rectum following colectomy and ileorectal anastomosis for ulcerative colitis.

Authors:  W N Baker; R E Glass; J K Ritchie; S O Aylett
Journal:  Br J Surg       Date:  1978-12       Impact factor: 6.939

8.  Prognosis of carcinoma in ulcerative colitis.

Authors:  J K Ritchie; P R Hawley; J E Lennard-Jones
Journal:  Gut       Date:  1981-09       Impact factor: 23.059

9.  Cancer morbidity in ulcerative colitis.

Authors:  P Prior; S N Gyde; J C Macartney; H Thompson; J A Waterhouse; R N Allan
Journal:  Gut       Date:  1982-06       Impact factor: 23.059

10.  The prognosis of carcinoma of the colon and rectum complicating ulcerative colitis.

Authors:  R G Hughes; T J Hall; G E Block; B Levin; A R Moossa
Journal:  Surg Gynecol Obstet       Date:  1978-01
View more
  23 in total

Review 1.  Cancer surveillance in inflammatory bowel disease.

Authors:  C N Bernstein
Journal:  Curr Gastroenterol Rep       Date:  1999-12

2.  Multiple microcarcinoids in a patient with long standing ulcerative colitis.

Authors:  T Matsumoto; Y Jo; R Mibu; M Hirahashi; T Yao; M Iida
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

3.  Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

Authors:  J A Eaden; J F Mayberry
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

4.  Bcl-2 expression in colorectal tumors: evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas.

Authors:  M Ilyas; I P Tomlinson; A M Hanby; T Yao; W F Bodmer; I C Talbot
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 5.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

6.  Quality indicators for colonoscopy.

Authors:  Douglas K Rex; Philip S Schoenfeld; Jonathan Cohen; Irving M Pike; Douglas G Adler; M Brian Fennerty; John G Lieb; Walter G Park; Maged K Rizk; Mandeep S Sawhney; Nicholas J Shaheen; Sachin Wani; David S Weinberg
Journal:  Am J Gastroenterol       Date:  2014-12-02       Impact factor: 10.864

7.  Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis.

Authors:  Bernhard W Renz; Wolfgang E Thasler; Gerhard Preissler; Tobias Heide; Philippe N Khalil; Michael Mikhailov; Karl-Walter Jauch; Martin E Kreis; Markus Rentsch; Axel Kleespies
Journal:  J Gastrointest Surg       Date:  2013-03-09       Impact factor: 3.452

Review 8.  What we could do now: molecular pathology of colorectal cancer.

Authors:  R S Houlston
Journal:  Mol Pathol       Date:  2001-08

9.  A decision analysis of surveillance for colorectal cancer in ulcerative colitis.

Authors:  F Delcò; A Sonnenberg
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

10.  Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis.

Authors:  M D Rutter; B P Saunders; G Schofield; A Forbes; A B Price; I C Talbot
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.